• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Aastrom Biosciences Inc

+ Add to Watchlist

ATQP:GR

3.045 EUR 0.274 9.89%

As of 09:38:23 ET on 08/22/2014.

Snapshot for Aastrom Biosciences Inc (ATQP)

Open: 2.691 Day's Range: 2.691 - 3.045 Volume: 8,000
Previous Close: 2.771 52wk Range: 2.279 - 5.360 1-Yr Rtn: -20.29%

Stock Chart for ATQP

No chart data available.
  • ATQP:GR 3.045
  • 1D
  • 1M
  • 1Y
2.771
Interactive ATQP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATQP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -3.7330
Est. PEG Ratio -
Market Cap (M EUR) 24.36
Shares Outstanding (M) 8.00
30 Day Average Volume 776
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATQP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATQP

Aastrom Biosciences, Inc. develops autologous stem/progenitor cell products for the repair/regeneration of tissues based on Tissue Repair Cell (TRC) adult stem cell technology. The Company's products contain bone marrow stem and progenitor cells that are produced from cells originating from the patient.

Dominick C Colangelo "Nick"Pres/CEO/Chief Acctg OfficerDaniel Orlando "Dan"Chief Operating Officer
Gerard J MichelVP:Corporate Development/CFO
More Company Profile & Key Executives for ATQP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil